GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity
- Conditions
- Cerebrovascular AccidentPost-Stroke Spasticity
- Interventions
- Drug: GSK1358820Drug: Placebo
- First Posted Date
- 2007-04-16
- Last Posted Date
- 2010-09-08
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 120
- Registration Number
- NCT00460655
- Locations
- 🇯🇵
GSK Investigational Site, Yamaguchi, Japan
A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults
- Conditions
- Nausea and Vomiting, Chemotherapy-Induced
- Interventions
- First Posted Date
- 2007-04-16
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 85
- Registration Number
- NCT00460707
- Locations
- 🇺🇸
GSK Investigational Site, Columbus, Ohio, United States
Lamictal Bipolar Observational Study
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2012-03-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 238
- Registration Number
- NCT00460226
Parkinson's Disease Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole
- Conditions
- Parkinson Disease
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2016-10-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 28
- Registration Number
- NCT00460148
- Locations
- 🇿🇦
GSK Investigational Site, George, Eastern Cape, South Africa
Clinical Study Of Migraine Evolution
- Conditions
- Migraine Headache
- First Posted Date
- 2007-04-13
- Last Posted Date
- 2008-04-15
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 250
- Registration Number
- NCT00460005
- Locations
- 🇨🇦
GSK Clinical Trials Call Centre, Montreal, Quebec, Canada
A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease
- Conditions
- Alzheimer's Disease
- Interventions
- Drug: GSK933776Drug: Placebo to match GSK933776
- First Posted Date
- 2007-04-12
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 50
- Registration Number
- NCT00459550
- Locations
- 🇸🇪
GSK Investigational Site, Stockholm, Sweden
Absorption, Distribution, Metabolism And Excretion Study For GSK221149A
- Conditions
- Obstetric Labour, PrematurePremature Labor
- First Posted Date
- 2007-04-09
- Last Posted Date
- 2012-03-19
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 6
- Registration Number
- NCT00457925
- Locations
- 🇺🇸
GSK Investigational Site, Madison, Wisconsin, United States
GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
- Conditions
- Ulcerative Colitis
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2009-05-18
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 16
- Registration Number
- NCT00457171
Complementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 Years
- Conditions
- Infections, Papillomavirus
- Interventions
- Biological: Cervarix TMBiological: Placebo
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 100
- Registration Number
- NCT00456807
- Locations
- 🇳🇱
GSK Investigational Site, Delft, Netherlands
Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.
- Conditions
- Hepatitis B
- Interventions
- Biological: Engerix™-B
- First Posted Date
- 2007-04-05
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 76
- Registration Number
- NCT00456625
- Locations
- 🇹🇭
GSK Investigational Site, Bangkok, Thailand